Compare Knight-Swift Transportation Holdings Inc. (KNX) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Knight-Swift Transportation Holdings Inc. vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Knight-Swift Transportation Holdings Inc. trades at $64.47 (market cap $10.59B), while Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B). The key difference: Knight-Swift Transportation Holdings Inc. is far larger — about 6.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Knight-Swift Transportation Holdings Inc. pays a 1.23% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Knight-Swift Transportation Holdings Inc. for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| KNX | NUVB | |
|---|---|---|
Market Cap | $10.59B | $1.74B |
Volume | 2,972,511 | 9,289,619 |
Sector | Industrials | Health |
52-Week High | $82.45 | $9.54 |
52-Week Low | $41.68 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.09B | $1.33B |
Dividend Yield | 1.23% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Knight-Swift Transportation Holdings Inc.
Knight-Swift provides truckload, less-than-truckload, logistics, and freight management services. It operates a large transportation network across North America.
Read more on KNX →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
